Decheng Capital LLC
CIK 2010850 · Holdings on Jun 30, 2024 · First reported Aug 14, 2024
Top ten holdings
Q2 2024- CGON52.81%
- NUVB6.22%
- RCUS4.06%
- ZNTL3.85%
- KRYS3.70%
- BYSI3.65%
- ILMN3.48%
- MRUS3.25%
- PHAT2.68%
- NAMS2.35%
Share classes counted separately86.05%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- CGONWeight increased · +20.67 pp32.14% → 52.81%Shares 0 (0.00%)
- MRUSWeight increased · +2.64 pp0.61% → 3.25%Shares +77.30K (+75.93%)
- KRYSWeight increased · +2.13 pp1.57% → 3.70%Shares 0 (0.00%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 24
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | CGONCG ONCOLOGY INC View history and evidence | $172.33M | 52.81% | 5.46M shares | 32.14% → 52.81%+20.67 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | NUVBNUVATION BIO INC View history and evidence | $20.29M | 6.22% | 6.95M shares | Prior unavailable +6.95M | New | ↗▾ |
| 03 | RCUSARCUS BIOSCIENCES INC View history and evidence | $13.25M | 4.06% | 869.79K shares | 2.20% → 4.06%+1.86 pp 0 (0.00%) | Unchanged | ↗▾ |
| 04 | ZNTLZENTALIS PHARMACEUTICALS INC View history and evidence | $12.56M | 3.85% | 3.07M shares | 4.44% → 3.85%-0.59 pp +970.86K (+46.24%) | Added | ↗▾ |
| 05 | KRYSKRYSTAL BIOTECH INC View history and evidence | $12.08M | 3.70% | 65.77K shares | 1.57% → 3.70%+2.13 pp 0 (0.00%) | Unchanged | ↗▾ |
| 06 | BYSIBEYONDSPRING INCSHS View history and evidence | $11.90M | 3.65% | 4.96M shares | 2.37% → 3.65%+1.28 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | ILMNILLUMINA INC View history and evidence | $11.35M | 3.48% | 108.77K shares | 2.38% → 3.48%+1.10 pp -20.30K (-15.73%) | Reduced | ↗▾ |
| 08 | MRUSMERUS NV View history and evidence | $10.60M | 3.25% | 179.10K shares | 0.61% → 3.25%+2.64 pp +77.30K (+75.93%) | Added | ↗▾ |
| 09 | PHATPHATHOM PHARMACEUTICALS INC View history and evidence | $8.76M | 2.68% | 850.00K shares | 1.21% → 2.68%+1.47 pp 0 (0.00%) | Unchanged | ↗▾ |
| 10 | NAMSNEWAMSTERDAM PHARMA CO NV View history and evidence | $7.68M | 2.35% | 400.00K shares | Prior unavailable +400.00K | New | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 4
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| NVLS ALPINE IMMUNE SCIENCES INC | Non-derivative | -8,317,924 | -$329.72M | SEC filing ↗ | SEC filing ↗ |
| TXG 10X GENOMICS INC-CLASS A | Non-derivative | -195,835 | -$7.35M | SEC filing ↗ | SEC filing ↗ |
| HLTHQ CUE HEALTH INC | Non-derivative | -8,980,909 | -$1.70M | SEC filing ↗ | SEC filing ↗ |
3 / 4 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 2010850 · Period 2024-06-30
Data loaded 2026-09-23 · First reported 2024-08-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 326315057
}Take these holdings further.
This page includes 24 of 24 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 24 of 24 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"2010850","quarter":"2024Q2","page_size":100}
get_institutional_manager_history
{"cik":"2010850","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.